125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer

Summary The rate of reduction in the concentration of serum human chorionic gonadotrophin (hCG) following chemotherapy for germ cell tumours may follow a complex pattern, with longer apparent half-life during later stages of chemotherapy, even in patients treated successfully. The commonly used half...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 1999-07, Vol.80 (10), p.1577-1581
Hauptverfasser:	Christensen, T B, Engbaek, F, Marqversen, J, Nielsen, S I, Kamby, C, Maase, H von der
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Biomarkers, Tumor - blood Biomedical and Life Sciences Biomedicine Bleomycin - administration & dosage Cancer Research Chorionic Gonadotropin - administration & dosage Chorionic Gonadotropin - blood Cisplatin - administration & dosage Drug Resistance Epidemiology Etoposide - administration & dosage Evaluation Studies as Topic Germinoma - blood Germinoma - drug therapy Gynecology. Andrology. Obstetrics Half-Life Humans Iodine Radioisotopes Male Male genital diseases Medical sciences Middle Aged Molecular Medicine Oncology Regular regular-article Remission Induction Testicular Neoplasms - blood Testicular Neoplasms - drug therapy Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!